NEA Management Company as of June 30, 2017
Portfolio Holdings for NEA Management Company
NEA Management Company holds 44 positions in its portfolio as reported in the June 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Tesaro | 52.3 | $1.4B | 10M | 139.86 | |
| Mersana Therapeutics (MRSN) | 4.1 | $114M | 8.1M | 13.97 | |
| Achaogen | 4.1 | $113M | 5.2M | 21.73 | |
| Dermira | 3.7 | $102M | 3.5M | 29.14 | |
| Glycomimetics (GLYC) | 3.5 | $96M | 8.6M | 11.16 | |
| Epizyme | 3.4 | $95M | 6.3M | 15.10 | |
| Ardelyx (ARDX) | 2.6 | $72M | 14M | 5.10 | |
| Ra Pharmaceuticals | 2.4 | $66M | 3.5M | 18.74 | |
| Senseonics Hldgs (SENS) | 2.2 | $60M | 33M | 1.80 | |
| Adaptimmune Therapeutics (ADAP) | 2.0 | $54M | 12M | 4.49 | |
| Crispr Therapeutics (CRSP) | 1.9 | $52M | 3.2M | 16.02 | |
| Care | 1.8 | $49M | 3.3M | 15.10 | |
| Lexicon Pharmaceuticals (LXRX) | 1.4 | $39M | 2.4M | 16.45 | |
| Groupon | 1.4 | $39M | 10M | 3.84 | |
| Tintri Inc. equity | 1.4 | $38M | 5.3M | 7.27 | |
| AVEO Pharmaceuticals | 1.3 | $36M | 16M | 2.22 | |
| Cascadian Therapeutics | 1.2 | $34M | 9.1M | 3.72 | |
| Strongbridge Bioph shs usd | 1.1 | $30M | 4.1M | 7.15 | |
| Aurinia Pharmaceuticals (AUPH) | 1.1 | $30M | 4.8M | 6.13 | |
| Obseva Sa | 1.0 | $29M | 3.3M | 8.55 | |
| Nevro (NVRO) | 1.0 | $27M | 360k | 74.43 | |
| Proteostasis Therapeutics In | 0.6 | $17M | 3.6M | 4.68 | |
| Snap Inc cl a (SNAP) | 0.5 | $15M | 814k | 17.77 | |
| Sucampo Pharmaceuticals | 0.5 | $13M | 1.3M | 10.50 | |
| Endologix | 0.4 | $12M | 2.5M | 4.86 | |
| Rigel Pharmaceuticals (RIGL) | 0.3 | $8.9M | 3.2M | 2.73 | |
| Trevena | 0.3 | $8.8M | 3.8M | 2.30 | |
| Affimed Therapeutics B V | 0.3 | $8.0M | 3.9M | 2.05 | |
| Verona Pharma Plc ads (VRNA) | 0.3 | $7.8M | 667k | 11.66 | |
| Tracon Pharmaceuticals | 0.2 | $6.6M | 2.8M | 2.40 | |
| Dasan Zhone Solutions | 0.2 | $5.7M | 956k | 6.00 | |
| Aerohive Networks | 0.2 | $5.6M | 1.1M | 5.00 | |
| Mirna Therapeutics | 0.2 | $5.0M | 3.0M | 1.67 | |
| Trillium Therapeutics, Inc. Cmn | 0.2 | $4.6M | 1.1M | 4.40 | |
| Champions Oncology (CSBR) | 0.1 | $4.0M | 1.6M | 2.57 | |
| Arca Biopharma | 0.1 | $3.5M | 1.5M | 2.40 | |
| Sunesis Pharmaceuticals Inc Ne | 0.1 | $3.5M | 1.3M | 2.70 | |
| ArQule | 0.1 | $3.1M | 2.5M | 1.24 | |
| Akari Therapeutics | 0.1 | $2.1M | 452k | 4.61 | |
| Roka Bioscience | 0.1 | $2.3M | 894k | 2.58 | |
| Paratek Pharmaceuticals | 0.1 | $1.6M | 66k | 24.11 | |
| Orexigen Therapeutics | 0.0 | $1.1M | 371k | 2.90 | |
| Cerecor | 0.0 | $339k | 595k | 0.57 | |
| Catalyst Biosciences | 0.0 | $202k | 44k | 4.64 |
